Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barbara A. Burtness, MD
Yale University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mbccop - San Juan
San Juan, Puerto Rico
- Veterans Affairs Medical Center - San Juan
San Juan, Puerto Rico
- Pretoria Academic Hospitals
Pretoria, South Africa
- Ccop - Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Beckman Research Institute, City of Hope
Los Angeles, California, United States
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Ccop - Colorado Cancer Research Program, Inc.
Denver, Colorado, United States
- Yale Comprehensive Cancer Center
New Haven, Connecticut, United States
- Ccop - Christiana Care Health Services
Wilmington, Delaware, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- Veterans Affairs Medical Center - Gainsville
Gainesville, Florida, United States
- Sylvester Cancer Center, University of Miami
Miami, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Veterans Affairs Medical Center - Tampa (haley)
Tampa, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Veterans Affairs Medical Center - Indianapolis (roudebush)
Indianapolis, Indiana, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Mbccop - Lsu Medical Center
New Orleans, Louisiana, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- New England Medical Center Hospital
Boston, Massachusetts, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- Veterans Affairs Medical Center - Minneapolis
Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Aug 1999
- Primary completion
- 30 Sept 2004
- Completion
- —
- Last update posted
- 27 Feb 2026
- Registered enrollment
- —
- Registry id
- NCT00003809
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.